Response to RAF/MEK/ERK Inhibitors in Patients with RAS-Altered and Wild-Type Tumors.

ABSTRACT:

SUBMITTER: Gouda MA 

PROVIDER: S-EPMC13625929 | biostudies-literature | 2026 Nov

REPOSITORIES: biostudies-literature